Duration of Humoral Immunity to Common Viral and Vaccine Antigens
Open accessAbstract
BACKGROUND: Maintenance of long-term antibody responses is critical for protective immunity against many pathogens. However, the duration of humoral immunity and the role played by memory B cells remain poorly defined. METHODS: We performed a longitudinal analysis of antibody titers specific for viral antigens (vaccinia, measles, mumps, rubella, varicella-zoster virus, and Epstein-Barr virus) and nonreplicating antigens (tetanus and diphtheria) in 45 subjects for a period of up to 26 years. In addition, we measured antigen-specific memory B cells by means of limiting-dilution analysis, and we compared memory B-cell frequencies to their corresponding serum antibody levels. RESULTS: Antiviral antibody responses were remarkably stable, with half-lives ranging from an estimated 50 years for varicella-zoster virus to more than 200 years for other viruses such as measles and mumps. Antibody responses against tetanus and diphtheria antigens waned more quickly, with estimated half-lives of 11 years and 19 years, respectively. B-cell memory was long-lived, but there was no significant correlation between peripheral memory B-cell numbers and antibody levels for five of the eight antigens tested. CONCLUSIONS: These studies provide quantitative analysis of serologic memory for multiple antigens in subjects followed longitudinally over the course of more than one decade. In cases in which multiple exposures or repeated vaccinations were common, memory B-cell numbers did not correlate with antibody titers. This finding suggests that peripheral memory B cells and antibody-secreting plasma cells may represent independently regulated cell populations and may play different roles in the maintenance of protective immunity.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Longer-term follow-up will likely show further slowing of neutralizing antibody decay, with titres reaching a stable level similar to other viral pathogens.
“It is likely that longer-term follow-up studies will reveal a further slowing of decay, with titres reaching a stable level analogous to humoral responses to other viral pathogens22,23.”
From Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection (2021) · cites this paper as [23]
Previous work has found that antibodies and memory B cells correlate for some vaccines or antigens, but do not correlate for many others.
“Previous work has found that antibodies and memory B cells correlate for some vaccines or antigens, but do not correlate for many others (34).”
From Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination (2021) · cites this paper as [34]
Most of the strongest neutralizing antibodies against SARS-CoV-2 identified so far bind the RBD.
“We focused on the RBD since it is the target of the majority of the more potent SARS-CoV-2 neutralizing antibodies discovered to date21–26.”
From mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants (2021) · cites this paper as [21]
Antibodies in classes 1 and 2 are both highly potent and highly abundant.
“Class 1 and 2 antibodies are among the most potent and also the most abundant antibodies7,8,21,22,25,39.”
From mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants (2021) · cites this paper as [21]
mRNA vaccines induce antibodies to RBD, the main target of neutralizing antibodies, in a way that resembles natural infection.
“The vaccines elicit antibody responses against the RBD, the major target of neutralizing antibodies21–26, in a manner that resembles natural infection.”
From mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants (2021) · cites this paper as [21]
Cites
Adjusting for multiple testing—when and how?
Bender, R., & Lange, S. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00314-0 · Cited by 3,060 · see citing works
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
Edwards, J. C. W., Szczepański, L., Szechiński, J., Filipowicz-Sosnowska, A., Emery, P., Close, D. R., Stevens, R. M., & Shaw, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032534 · Cited by 2,623 · see citing works
Immunological memory and protective immunity: understanding their relation
Ahmed, R., & Gray, D. (1996) · Science · doi:10.1126/science.272.5258.54 · Cited by 1,775 · see citing works
Maintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells
Bernasconi, N. L., Traggiai, E., & Lanzavecchia, A. (2002) · Science · doi:10.1126/science.1076071 · Cited by 1,304 · see citing works
Humoral Immunity Due to Long-Lived Plasma Cells
Slifka, M. K., Antia, R., Whitmire, J. K., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80541-5 · Cited by 1,249 · see citing works
Self-citationCompetence and competition: the challenge of becoming a long-lived plasma cell
Radbruch, A., Muehlinghaus, G., Luger, E., Inamine, A., Smith, K. G. C., Dörner, T., & Hiepe, F. (2006) · Nature reviews. Immunology · doi:10.1038/nri1886 · Cited by 1,033 · see citing works
Duration of antiviral immunity after smallpox vaccination
Hammarlund, E., Lewis, M. W., Hansen, S. G., Strelow, L. I., Nelson, J. A., Sexton, G. J., Hanifin, J. M., & Slifka, M. K. (2003) · Nature Medicine · doi:10.1038/nm917 · Cited by 946 · see citing works
Self-citationLifetime of plasma cells in the bone marrow
Manz, R. A., Thiel, A., & Radbruch, A. (1997) · Nature · doi:10.1038/40540 · Cited by 866 · see citing works
Cutting edge: long-term B cell memory in humans after smallpox vaccination
Crotty, S., Felgner, P., Davies, H., Glidewell, J., Villarreal, L., & Ahmed, R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.4969 · Cited by 695 · see citing works
Measles Antibody: Reevaluation of Protective Titers
Chen, R. T., Markowitz, L. E., Albrecht, P. G., Stewart, J. A., MOFENSON, L. M., Preblud, S. R., & Orenstein, W. A. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/162.5.1036 · Cited by 606 · see citing works
MAINTENANCE OF SERUM ANTIBODY LEVELS
Manz, R. A., Hauser, A. E., Hiepe, F., & Radbruch, A. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115723 · Cited by 540 · see citing works
Zinkernagel, R. M., Bachmann, M. F., Kündig, T. M., Oehen, S., Pirchet, H., & Hengartner, H. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.333 · Cited by 474 · see citing works
Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis
Cambridge, G., Leandro, M. J., Edwards, J., Ehrenstein, M. R., Salden, M., Bodman‐Smith, M. D., & WEBSTER, A. D. B. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11181 · Cited by 470 · see citing works
Parker, A. A., Staggs, W., Dayan, G. H., Ortega‐Sanchez, I. R., Rota, P. A., Lowe, L., Boardman, P., Teclaw, R. F., Graves, C., & LeBaron, C. W. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060775 · Cited by 290 · see citing works
Blink, E. J., Light, A., Kallies, A., Nutt, S. L., Hodgkin, P. D., & Tarlinton, D. M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042060 · Cited by 259 · see citing works
Immunity and immunological memory following smallpox vaccination
Amanna, I. J., Slifka, M. K., & Crotty, S. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00392.x · Cited by 231 · see citing works
Self-citationI mmunological M emory to V iral I nfections
Welsh, R. M., Selin, L. K., & Szomolanyi‐Tsuda, E. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104527 · Cited by 215 · see citing works
Rubella Immunity:Defining the Level of Protective Antibody
Skendzel, L. P. (1996) · American Journal of Clinical Pathology · doi:10.1093/ajcp/106.2.170 · Cited by 180 · see citing works
Monath, T. P. C., Nichols, R., Archambault, W. T., Moore, L., Marchesani, R., Tian, J., Shope, R. E., Thomas, N., Schrader, R., Furby, D., et al. (2002) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2002.66.533 · Cited by 179 · see citing works
A Prospective Study of Serum Antibody and Protection Against Smallpox
Mack, T. M., Noble, J., & Thomas, D. B. (1972) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1972.21.214 · Cited by 160 · see citing works
Circulating Antitoxin at the Onset of Diphtheria in 425 Patients
Ipsen, J. (1946) · The Journal of Immunology · doi:10.4049/jimmunol.54.4.325 · Cited by 149 · see citing works
Antigen dependent and independent mechanisms that sustain serum antibody levels
Traggiai, E., Puzone, R., & Lanzavecchia, A. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00198-1 · Cited by 140 · see citing works
Leyendeckers, H., Odendahl, M., Löhndorf, A., Irsch, J., Spangfort, M. D., Miltenyi, S., Hunzelmann, N., Assenmacher, M., Radbruch, A., & Schmitz, J. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199904)29:04 · Cited by 135 · see citing works
Quinn, C. P., Dull, P. M., Semenova, V. A., Li, H., Crotty, S., Taylor, T. H., Steward‐Clark, E., Stamey, K., Schmidt, D. S., Stinson, K. W., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/423937 · Cited by 129 · see citing works
ELISA for the routine determination of antitoxic immunity to tetanus
Simonsen, O., Bentzon, M. W., & Heron, I. (1986) · Journal of Biological Standardization · doi:10.1016/0092-1157(86)90008-9 · Cited by 127 · see citing works
Long-term humoral immunity against viruses: revisiting the issue of plasma cell longevity
Slifka, M. K., & Ahmed, R. (1996) · Trends in Microbiology · doi:10.1016/0966-842x(96)10059-7 · Cited by 109 · see citing works
Self-citationNanan, R. K. H., Heinrich, D., Frosch, M., & Kreth, H. W. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00328-0 · Cited by 95 · see citing works
Quantitation of rare memory B cell populations by two independent and complementary approaches
Amanna, I. J., & Slifka, M. K. (2006) · Journal of Immunological Methods · doi:10.1016/j.jim.2006.09.005 · Cited by 92 · see citing works
Self-citationO’Connor, B. P., Gleeson, M. W., Noelle, R. J., & Erickson, L. D. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00055.x · Cited by 88 · see citing works
Checkpoints in memory B‐cell evolution
McHeyzer‐Williams, L. J., Malherbe, L. P., & McHeyzer‐Williams, M. G. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00397.x · Cited by 65 · see citing works
Long-Term Immunity to Tetanus—A Statistical Evaluation and its Clinical Implications
Gottlieb, S., McLaughlin, F. X., Levine, L., Latham, W. C., & Edsall, G. (1964) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.54.6.961 · Cited by 64 · see citing works
Slifka, M. K., & Ahmed, R. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb52958.x · Cited by 51 · see citing works
Self-citationRubella antibody persistence after immunization.
Herrmann, K. L., Halstead, S. B., & Wiebenga, N. H. (1982) · PubMed · Cited by 46 · see citing works
Evaluation of vaccination requirements to secure continuous antitoxin immunity to tetanus
SIMONSEN, O., Bentzon, M. W., Kjeldsen, K. P., VENBORG, H., & Heron, I. (1987) · Vaccine · doi:10.1016/0264-410x(87)90057-0 · Cited by 42 · see citing works
Safety and Pharmacokinetic Evaluation of Intravenous Vaccinia Immune Globulin in Healthy Volunteers
Hopkins, R. J., Kramer, W. G., Blackwelder, W. C., Ashtekar, M. D., Hague, L., Roche, S. D. W.-L., Berezuk, G. P., Smith, D. R., & Leese, P. T. (2004) · Clinical Infectious Diseases · doi:10.1086/422998 · Cited by 40 · see citing works
Fall‐off in immunity following diphtheria revaccination ‐ an 8 year follow‐up study
Simonsen, O., Kristiansen, M. P., Aggerbeck, H., Hau, C., & Heron, I. (1996) · Apmis · doi:10.1111/j.1699-0463.1996.tb04959.x · Cited by 21 · see citing works
Rubella antibody persistence after immunization
Herrmann, K. L. (1982) · JAMA · doi:10.1001/jama.247.2.193 · Cited by 13 · see citing works
The duration of immunity following diphtheria vaccination.
Bojlén, K., & SCHEIBEL, I. (1955) · PubMed · Cited by 11 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Khoury, D. S., Cromer, D., Reynaldi, A., Schlub, T. E., Wheatley, A. K., Juno, J. A., Subbarao, K., Kent, S. J., Triccas, J. A., & Davenport, M. P. (2021) · Nature Medicine · doi:10.1038/s41591-021-01377-8 · Cited by 3,742 · see citing works
Vaccine Adjuvants: Putting Innate Immunity to Work
Coffman, R. L., Sher, A., & Seder, R. A. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.002 · Cited by 1,927 · see citing works
Seow, J., Graham, C., Merrick, B., Acors, S., Pickering, S., Steel, K. J. A., Hemmings, O., O’Byrne, A., Kouphou, N., Galao, R. P., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00813-8 · Cited by 1,419 · see citing works
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Wang, Z., Schmidt, F., Weisblum, Y., Muecksch, F., Barnes, C. O., Finkin, S., Schaefer-Babajew, D., Cipolla, M., Gaebler, C., Lieberman, J. A., et al. (2021) · Nature · doi:10.1038/s41586-021-03324-6 · Cited by 1,343 · see citing works
Expanding roles for CD4+ T cells in immunity to viruses
Swain, S. L., McKinstry, K. K., & Strutt, T. M. (2012) · Nature reviews. Immunology · doi:10.1038/nri3152 · Cited by 960 · see citing works
Vaccines: Correlates of Vaccine‐Induced Immunity
Plotkin, S. A. (2008) · Clinical Infectious Diseases · doi:10.1086/589862 · Cited by 829 · see citing works
A review of clinical trials of human papillomavirus prophylactic vaccines
Schiller, J. T., Castellsagué, X., & Garland, S. M. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.108 · Cited by 747 · see citing works
B-cell responses to vaccination at the extremes of age
Siegrist, C.-A., & Aspinall, R. (2009) · Nature Reviews Immunology · doi:10.1038/nri2508 · Cited by 659 · see citing works
Goel, R. R., Apostolidis, S. A., Painter, M. M., Mathew, D., Pattekar, A., Kuthuru, O., Gouma, S., Hicks, P., Meng, W., Rosenfeld, A. M., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abi6950 · Cited by 655 · see citing works
Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19
Rodda, L. B., Netland, J., Shehata, L., Pruner, K. B., Morawski, P. A., Thouvenel, C. D., Takehara, K. K., Eggenberger, J., Hemann, E. A., Waterman, H. R., et al. (2021) · Cell · doi:10.1016/j.cell.2020.11.029 · Cited by 647 · see citing works
From Vaccines to Memory and Back
Sallusto, F., Lanzavecchia, A., Araki, K., & Ahmed, R. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.008 · Cited by 631 · see citing works
Different B Cell Populations Mediate Early and Late Memory During an Endogenous Immune Response
Pape, K. A., Taylor, J. J., Maul, R. W., Gearhart, P. J., & Jenkins, M. K. (2011) · Science · doi:10.1126/science.1201730 · Cited by 572 · see citing works
Long-Lived Plasma Cells Are Contained within the CD19−CD38hiCD138+ Subset in Human Bone Marrow
Halliley, J. L., Tipton, C. M., Liesveld, J. L., Rosenberg, A. F., Darce, J. R., Gregoretti, I. V., Popova, L., Kaminiski, D. A., Fucile, C., Albizua, I., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.06.016 · Cited by 545 · see citing works
Self-citationTang, F., Quan, Y., Xin, Z.-T., Wrammert, J., Ma, M.-J., Lv, H., Wang, T.-B., Yang, H., Richardus, J. H., Liu, W., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.0903490 · Cited by 496 · see citing works
B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study
Haynes, B. F., Kelsoe, G. H., Harrison, S. C., & Kepler, T. B. (2012) · Nature Biotechnology · doi:10.1038/nbt.2197 · Cited by 481 · see citing works
Broadly Neutralizing Antiviral Antibodies
Corti, D., & Lanzavecchia, A. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095916 · Cited by 469 · see citing works
Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens
Mina, M. J., Kula, T., Leng, Y., Li, M., de Vries, R. D., Knip, M., Siljander, H., Rewers, M., Choy, D. F., Wilson, M. S., et al. (2019) · Science · doi:10.1126/science.aay6485 · Cited by 466 · see citing works
Burbelo, P. D., Riedo, F. X., Morishima, C., Rawlings, S. A., Smith, D. M., Das, S., Strich, J. R., Chertow, D. S., Davey, R. T., & Cohen, J. I. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa273 · Cited by 466 · see citing works
Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors
Yu, X., Tsibane, T., McGraw, P. A., House, F. S., Keefer, C. J., Hicar, M. D., Tumpey, T. M., Pappas, C., Perrone, L. A., Martinez, O., et al. (2008) · Nature · doi:10.1038/nature07231 · Cited by 448 · see citing works
Cohen, K. W., Linderman, S. L., Moodie, Z., Czartoski, J., Lai, L., Mantus, G., Norwood, C., Nyhoff, L. E., Edara, V. V., Floyd, K., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100354 · Cited by 441 · see citing works
Long-lived autoreactive plasma cells drive persistent autoimmune inflammation
Hiepe, F., Dörner, T., Hauser, A. E., Hoyer, B. F., Mei, H. E., & Radbruch, A. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.1 · Cited by 390 · see citing works
Ellebedy, A. H., Jackson, K., Kissick, H. T., Nakaya, H. I., Davis, C. W., Roskin, K. M., McElroy, A. K., Oshansky, C. M., Elbein, R., Thomas, S., et al. (2016) · Nature Immunology · doi:10.1038/ni.3533 · Cited by 384 · see citing works
White, M. T., Verity, R., Griffin, J. T., Asante, K. P., Owusu‐Agyei, S., Greenwood, B. M., DRAKELEY, C. J., Gesase, S., Lusingu, J., Ansong, D., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00239-x · Cited by 383 · see citing works
Diversity in T Cell Memory: An Embarrassment of Riches
Jameson, S. C., & Masopust, D. (2009) · Immunity · doi:10.1016/j.immuni.2009.11.007 · Cited by 382 · see citing works
The Role of Antibodies in HIV Vaccines
Mascola, J. R., & Montefiori, D. C. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101256 · Cited by 382 · see citing works
Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
Wheatley, A. K., Juno, J. A., Wang, J. J., Selva, K. J., Reynaldi, A., Tan, H.-X., Lee, W. S., Wragg, K. M., Kelly, H. G., Esterbauer, R., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21444-5 · Cited by 351 · see citing works
Mechanisms that determine plasma cell lifespan and the duration of humoral immunity
Amanna, I. J., & Slifka, M. K. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00912.x · Cited by 343 · see citing works
Self-citationMaturation and persistence of the anti-SARS-CoV-2 memory B cell response
Sokal, A., Chappert, P., Barba-Spaeth, G., Roeser, A., Fourati, S., Azzaoui, I., Vandenberghe, A., Fernandez, I., Meola, A., Bouvier-Alias, M., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.050 · Cited by 340 · see citing works
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact
Lipsitch, M., Krammer, F., Regev‐Yochay, G., Lustig, Y., & Balicer, R. D. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00662-4 · Cited by 340 · see citing works
Moss, W. J., & Griffin, D. E. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62352-5 · Cited by 337 · see citing works
Ripperger, T. J., Uhrlaub, J. L., Watanabe, M., Wong, R., Castaneda, Y., Pizzato, H. A., Thompson, M. R., Bradshaw, C. M., Weinkauf, C. C., Bime, C., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.10.004 · Cited by 330 · see citing works
Mcl-1 is essential for the survival of plasma cells
Peperzak, V., Vikstrom, I. B., Walker, J. A., Glaser, S. P., LePage, M., Coquery, C. M., Erickson, L. D., Fairfax, K. A., Mackay, F., Strasser, A., et al. (2013) · Nature Immunology · doi:10.1038/ni.2527 · Cited by 321 · see citing works
Crompton, P. D., Moebius, J., Portugal, S., Waisberg, M., Hart, G. T., Garver, L. S., Miller, L. H., Barillas-Mury, C. V., & Pierce, S. K. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120220 · Cited by 319 · see citing works
Alexander, T., Thiel, A., Rosen, O., Massenkeil, G., Sattler, A., Köhler, S., Mei, H. E., Radtke, H., Gromnica‐Ihle, E., Burmester, G. R., et al. (2008) · Blood · doi:10.1182/blood-2008-07-168286 · Cited by 316 · see citing works
Lambert, N. D., Strebel, P. M., Orenstein, W. A., Icenogle, J. P., & Poland, G. A. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60539-0 · Cited by 313 · see citing works
New insights into the role of antinuclear antibodies in systemic lupus erythematosus
Pisetsky, D. S., & Lipsky, P. E. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0480-7 · Cited by 311 · see citing works
Understanding and learning from the success of prophylactic human papillomavirus vaccines
Schiller, J. T., & Lowy, D. R. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2872 · Cited by 295 · see citing works
Habibi, M. S., Jóźwik, A., Makris, S., Dunning, J. W., Paras, A., DeVincenzo, J. P., de Haan, C. A. M., Wrammert, J., Openshaw, P., & Chiu, C. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201412-2256oc · Cited by 289 · see citing works
Memory B and memory plasma cells
Yoshida, T., Mei, H. E., Dörner, T., Hiepe, F., Radbruch, A., Fillatreau, S., & Hoyer, B. F. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00938.x · Cited by 288 · see citing works
Mitochondrial Pyruvate Import Promotes Long-Term Survival of Antibody-Secreting Plasma Cells
Lam, W. Y., Becker, A. M., Kennerly, K., Wong, R., Curtis, J. D., Llufrio, E. M., McCommis, K. S., Fahrmann, J. F., Pizzato, H. A., Nunley, R. M., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.06.011 · Cited by 285 · see citing works
SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond
Bettini, E., & Locci, M. (2021) · Vaccines · doi:10.3390/vaccines9020147 · Cited by 283 · see citing works
Remembrance of Things Past: Long-Term B Cell Memory After Infection and Vaccination
Palm, A.-K. E., & Henry, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01787 · Cited by 281 · see citing works
Bhoj, V. G., Arhontoulis, D. C., Wertheim, G. B. W., Capobianchi, J., Callahan, C. A., Ellebrecht, C. T., Obstfeld, A. E., Lacey, S. F., Melenhorst, J. J., Nazimuddin, F., et al. (2016) · Blood · doi:10.1182/blood-2016-01-694356 · Cited by 278 · see citing works
T follicular helper cells in space-time
Qi, H. (2016) · Nature reviews. Immunology · doi:10.1038/nri.2016.94 · Cited by 272 · see citing works
Advances in Human B Cell Phenotypic Profiling
Kaminski, D. A., Wei, C., Yu, Q., Rosenberg, A. F., & Sanz, I. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00302 · Cited by 271 · see citing works
Human peripheral blood B‐cell compartments: A crossroad in B‐cell traffic
Pérez‐Andrés, M., Paiva, B., Nieto, W. G., Caraux, A., Schmitz, A., Almeida, J., Vogt, R. F., Marti, G. E., Rawstron, A. C., van Zelm, M. C., et al. (2010) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20547 · Cited by 269 · see citing works
Immunological memory to SARS‐CoV ‐2 infection and COVID ‐19 vaccines
Sette, A., & Crotty, S. (2022) · Immunological Reviews · doi:10.1111/imr.13089 · Cited by 266 · see citing works
Crawford, K. H. D., Dingens, A. S., Eguia, R., Wolf, C. R., Wilcox, N., Logue, J. K., Shuey, K., Casto, A. M., Fiala, B., Wrenn, S., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa618 · Cited by 265 · see citing works
Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection
Cromer, D., Juno, J. A., Khoury, D., Reynaldi, A., Wheatley, A. K., Kent, S. J., & Davenport, M. P. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00550-x · Cited by 265 · see citing works
Contributions of humoral and cellular immunity to vaccine-induced protection in humans
Amanna, I. J., & Slifka, M. K. (2011) · Virology · doi:10.1016/j.virol.2010.12.016 · Cited by 263 · see citing works
Self-citationBlood-borne human plasma cells in steady state are derived from mucosal immune responses
Mei, H. E., Yoshida, T., Sime, W., Hiepe, F., Thiele, K., Manz, R. A., Radbruch, A., & Dörner, T. (2008) · Blood · doi:10.1182/blood-2008-04-153544 · Cited by 259 · see citing works
Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination
Cho, A., Muecksch, F., Schaefer-Babajew, D. J., Wang, Z., Finkin, S., Gaebler, C., Ramos, V., Cipolla, M., Mendoza, P., Agudelo, M., et al. (2021) · Nature · doi:10.1038/s41586-021-04060-7 · Cited by 254 · see citing works
Wipasa, J., Suphavilai, C., Okell, L., Cook, J. A., Corran, P. H., Thaikla, K., Liewsaree, W., Riley, E. M., & Hafalla, J. C. R. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000770 · Cited by 248 · see citing works
Mietzner, B., Tsuiji, M., Scheid, J. F., Velinzon, K., Tiller, T., Abraham, K., González, J., Pascual, V., Stichweh, D., Wardemann, H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803644105 · Cited by 241 · see citing works
Lavinder, J. J., Wine, Y., Giesecke‐Thiel, C., Ippolito, G. C., Horton, A. P., Lungu, O. I., Hoi, K. H., DeKosky, B. J., Murrin, E. M., Wirth, M. M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317793111 · Cited by 239 · see citing works
Weiss, G. E., Traore, B., Kayentao, K., Ongoïba, A., Doumbo, S., Doumtabé, D., Koné, Y., Dia, S., Guindo, A., Traoré, A., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000912 · Cited by 237 · see citing works
Evolutionary biology of high-risk multiple myeloma
Pawlyn, C., & Morgan, G. J. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.63 · Cited by 237 · see citing works
Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors
Shroff, R. T., Chalasani, P., Wei, R., Pennington, D., Quirk, G., Schoenle, M. V., Peyton, K. L., Uhrlaub, J. L., Ripperger, T. J., Jergović, M., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01542-z · Cited by 233 · see citing works
Influence of Prior Influenza Vaccination on Antibody and B-Cell Responses
Sasaki, S., He, X.-S., Holmes, T. H., Dekker, C. L., Kemble, G. W., Arvin, A. M., & Greenberg, H. B. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002975 · Cited by 229 · see citing works
A unique population of IgG-expressing plasma cells lacking CD19 is enriched in human bone marrow
Mei, H. E., Wirries, I., Frölich, D., Brisslert, M., Giesecke‐Thiel, C., Grün, J. R., Alexander, T., Schmidt, S., Luda, K. M., Kühl, A. A., et al. (2015) · Blood · doi:10.1182/blood-2014-02-555169 · Cited by 228 · see citing works
Neutralization of Virus Infectivity by Antibodies: Old Problems in New Perspectives
Klasse, P. J. (2014) · Advances in Biology · doi:10.1155/2014/157895 · Cited by 227 · see citing works
Inoue, T., & Kurosaki, T. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00897-3 · Cited by 227 · see citing works
Explanations for the high potency of HPV prophylactic vaccines
Schiller, J. T., & Lowy, D. R. (2018) · Vaccine · doi:10.1016/j.vaccine.2017.12.079 · Cited by 226 · see citing works
Frasca, D., Diaz, A., Romero, M., Garcia, D., & Blomberg, B. B. (2020) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-011620-034148 · Cited by 226 · see citing works
Obeng-Adjei, N., Portugal, S., Tran, T. M., Yazew, T., Skinner, J., Li, S., Jain, A., Felgner, P. L., Doumbo, O. K., Kayentao, K., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.004 · Cited by 224 · see citing works
Safaeian, M., Porras, C., Pan, Y., Kreimer, A. R., Schiller, J. T., González, P., Lowy, D. R., Wacholder, S., SCHIFFMAN, M. H., Rodríguez, A. C., et al. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0203 · Cited by 223 · see citing works
Clonal dissection of the human memory B‐cell repertoire following infection and vaccination
Pinna, D., Corti, D., Jarrossay, D., Sallusto, F., & Lanzavecchia, A. (2009) · European Journal of Immunology · doi:10.1002/eji.200839129 · Cited by 222 · see citing works
Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT Trial
Kreimer, A. R., Sampson, J. N., Porras, C., Schiller, J. T., Kemp, T. J., Herrero, R., Wagner, S. A., Boland, J. F., Schussler, J. E., Lowy, D. R., et al. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa011 · Cited by 220 · see citing works
Wang, S., Liang, B., Wang, W., Li, L., Feng, N., Zhao, Y., Wang, T., Yan, F., Yang, S., & Xia, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01408-5 · Cited by 222 · see citing works
The human spleen is a major reservoir for long-lived vaccinia virus–specific memory B cells
Mamani‐Matsuda, M., Cosma, A., Weller, S., Faili, A., Staib, C., Garçon, L., Hermine, O., Beyne‐Rauzy, O., Fieschi, C., Pers, J., et al. (2008) · Blood · doi:10.1182/blood-2007-11-123844 · Cited by 219 · see citing works
A guide to adaptive immune memory
Lam, N., Lee, Y. S., & Färber, D. L. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01040-6 · Cited by 217 · see citing works
A method for identification of HIV gp140 binding memory B cells in human blood
Scheid, J. F., Mouquet, H., Feldhahn, N., Walker, B. D., Pereyra, F., Cutrell, E., Seaman, M. S., Mascola, J. R., Wyatt, R. T., Wardemann, H., et al. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.11.012 · Cited by 212 · see citing works
Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection
Zhang, A., Stacey, H. D., D’Agostino, M. R., Tugg, Y., Marzok, A., & Miller, M. S. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00813-1 · Cited by 212 · see citing works
Dengue: knowledge gaps, unmet needs, and research priorities
Katzelnick, L. C., Coloma, J., & Harris, E. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30473-x · Cited by 211 · see citing works
Plasma cell survival in the absence of B cell memory
Hammarlund, E., Thomas, A., Amanna, I. J., Holden, L. A., Slayden, O. D., Park, B., Gao, L., & Slifka, M. K. (2017) · Nature Communications · doi:10.1038/s41467-017-01901-w · Cited by 210 · see citing works
Self-citationHatano, H., Delwart, E., Norris, P. J., Lee, T., Dunn-Williams, J., Hunt, P. W., Hoh, R., Stramer, S. L., Linnen, J. M., McCune, J. M., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01763-08 · Cited by 208 · see citing works
B cells as therapeutic targets in autoimmune neurological disorders
Dalakas, M. C. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0901 · Cited by 204 · see citing works
B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells
Mahévas, M., Patin, P., Huetz, F., Descatoire, M., Cagnard, N., Bôle‐Feysot, C., Gallou, S. L., Khellaf, M., Fain, O., Boutboul, D., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci65689 · Cited by 200 · see citing works
Atypical and classical memory B cells produce Plasmodium falciparum neutralizing antibodies
Muellenbeck, M. F., Ueberheide, B. M., Amulic, B., Epp, A., Fenyö, D., Busse, C. E., Esen, M., Theisen, M., Mordmüller, B. G., & Wardemann, H. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20121970 · Cited by 199 · see citing works
Survival of Long-Lived Plasma Cells (LLPC): Piecing Together the Puzzle
Lightman, S. M., Utley, A. T., & Lee, K. P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00965 · Cited by 198 · see citing works
Challenges and strategies for developing efficacious and long-lasting malaria vaccines
Beeson, J. G., Kurtovic, L., Dobaño, C., Opi, D. H., Chan, J.-A., Feng, G., Good, M. F., Reiling, L., & Boyle, M. J. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau1458 · Cited by 195 · see citing works
Contributions of Antinucleoprotein IgG to Heterosubtypic Immunity against Influenza Virus
LaMere, M. W., Lam, H.-T., Moquin, A., Haynes, L., Lund, F. E., Randall, T. D., & Kaminski, D. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003057 · Cited by 193 · see citing works
Miller, M. S., Gardner, T. J., Krammer, F., Aguado, L. C., Tortorella, D., Basler, C. F., & Palese, P. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006637 · Cited by 190 · see citing works
Kernéis, S., Launay, O., Turbelin, C., Batteux, F., Hanslik, T., & Boëlle, P. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit937 · Cited by 190 · see citing works
Miho, E., Yermanos, A., Weber, C. R., Berger, C. T., Reddy, S. T., & Greiff, V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00224 · Cited by 189 · see citing works
Levesque, M. C., Moody, M. A., Hwang, K.-K., Marshall, D. J., Whitesides, J. F., Amos, J. D., Gurley, T. C., Allgood, S. D., Haynes, B. B., Vandergrift, N., et al. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000107 · Cited by 184 · see citing works
Sustained antibody responses depend on CD28 function in bone marrow–resident plasma cells
Rozanski, C. H., Arens, R., Carlson, L. M., Nair, J. R., Boise, L., Chanan-Khan, A. A., Schoenberger, S. P., & Lee, K. P. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20110040 · Cited by 184 · see citing works
Memory B cells and plasma cells: The differentiative continuum of humoral immunity
Cancro, M. P., & Tomayko, M. M. (2021) · Immunological Reviews · doi:10.1111/imr.13016 · Cited by 180 · see citing works
Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production
Chen, Y., Zuiani, A., Fischinger, S., Mullur, J., Atyeo, C. G., Travers, M. E., Lelis, F., Pullen, K. M., Martin, H., Tong, P., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.051 · Cited by 179 · see citing works
Markowitz, L. E., & Schiller, J. T. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa621 · Cited by 178 · see citing works
Studies of the immune response in heparin-induced thrombocytopenia
Warkentin, T. E., Sheppard, J. I., Moore, J. C., Cook, R. J., & Kelton, J. G. (2009) · Blood · doi:10.1182/blood-2008-10-186064 · Cited by 177 · see citing works
The role of B cells and humoral immunity in Mycobacterium tuberculosis infection
Chan, J., Mehta, S., Bharrhan, S., Chen, Y., Achkar, J. M., Casadevall, A., & Flynn, J. L. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.10.005 · Cited by 176 · see citing works
B-cell-directed therapies for autoimmune disease
Dörner, T., Radbruch, A., & Burmester, G. R. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.141 · Cited by 176 · see citing works
Vaccines for preventing herpes zoster in older adults
Gagliardi, A. M., Andriolo, B. N., Torloni, M. R., & Soares, B. G. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008858.pub3 · Cited by 175 · see citing works
Adhikari, U. K., Tayebi, M., & Rahman, M. (2018) · Journal of Immunology Research · doi:10.1155/2018/6718083 · Cited by 174 · see citing works
Malaria prevention: from immunological concepts to effective vaccines and protective antibodies
Cockburn, I. A., & Seder, R. A. (2018) · Nature Immunology · doi:10.1038/s41590-018-0228-6 · Cited by 169 · see citing works
Pensieroso, S., Cagigi, A., Palma, P., Nilsson, A., Capponi, C., Freda, E., Bernardi, S., Thorstensson, R., Chiodi, F., & Rossi, P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901702106 · Cited by 164 · see citing works
Zuiani, A., Dulberger, C. L., Silva, N. S. D., Marquette, M., Lu, Y.-J., Palowitch, G. M., Dokic, A., Sanchez-Velazquez, R., Schlatterer, K., Sarkar, S., et al. (2024) · Cell · doi:10.1016/j.cell.2024.01.017 · Cited by 162 · see citing works
Walsh, R. C., Brailey, P. A., Girnita, A. L., Alloway, R. R., Shields, A. R., Wall, G. E., Sadaka, B. H., Cardi, M. A., Tevar, A. D., Govil, A., et al. (2011) · Transplantation · doi:10.1097/tp.0b013e318218e901 · Cited by 161 · see citing works
Moris, P., der Most, R. G. V., Leroux‐Roels, I., Clément, F., Dramé, M., Hanon, E., Leroux-Roels, G. G., & Mechelen, M. V. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9490-6 · Cited by 159 · see citing works
- Authors
- Amanna, I. J., Carlson, N. E., & Slifka, M. K.
- Affiliations
- Oregon Health & Science University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-11-08
- Volume
- 357
- Issue
- 19
- Pages
- 1903-1915
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2128666074
- Cited by
- 1,286
- References
- 38
- Citations by year
- 2026: 60 · 2025: 81 · 2024: 82 · 2023: 72 · 2022: 103 · 2021: 127 · 2020: 73 · 2019: 60 · 2018: 64 · 2017: 64 · 2016: 52 · 2015: 47 · 2014: 68 · 2013: 67 · 2012: 66
- FWCI
- 17.94
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (P01AG023664)
- National Center for Research Resources (RR000163, P51RR000163, M01RR000334, UL1RR024140, RR024140, RR 000334)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- humoral immunity, antibody half-life, memory B cells, long-term antibody persistence, vaccine antigens, measles, mumps, rubella, varicella-zoster virus, Epstein-Barr virus, tetanus toxoid, diphtheria toxoid, protective immunity
- MeSH terms
- Adult, Aging, Antibodies, Bacterial, Antibodies, Viral, Antibody Formation, Antigens, Bacterial, Antigens, Viral, B-Lymphocytes, Diphtheria, Female, Half-Life, Humans, Longitudinal Studies, Male, Middle Aged, Plasma Cells, Tetanus, Time Factors, Vaccines, Virus Diseases, Seroepidemiologic Studies, Lymphocyte Count
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review